中华实验外科杂志
中華實驗外科雜誌
중화실험외과잡지
CHINESE JOURNAL OF EXPERIMENTAL SURGERY
2010年
2期
192-194
,共3页
程锐%王帅%刘涛%王春友%万赤丹
程銳%王帥%劉濤%王春友%萬赤丹
정예%왕수%류도%왕춘우%만적단
脂肪肝%解耦联蛋白-2%缺血%再灌注损伤
脂肪肝%解耦聯蛋白-2%缺血%再灌註損傷
지방간%해우련단백-2%결혈%재관주손상
Fatty liver%Uncouphng protein-2%Ischemia%Reperfusion injury
目的 观察解耦联蛋白-2(UCP-2)基因在脂肪肝缺血再灌注损伤中的作用,探讨以UCP-2为靶点的脂肪供肝预处理新途径.方法 实验动物分为3组:实验组(A组):UCP-2基因敲除小鼠,给予高脂饮食(n=20);空白对照组(B组):野生型同系小鼠,给予正常饮食(n=20);阴性对照组(C组):野生型同系小鼠,给予高脂饮食(n=20).喂养6个月,建屯小鼠脂肪肝模型.各组小鼠阻断门静脉缺血15 min,再灌注24 h后处死,检测肝组织中UCP-2基因表达及三磷酸腺苷(ATP)、活性氧族(ROS)、乳酸脱氢酶(LDH)水平;并行血清丙氨酸转氨酶(ALT)、天门冬氨酸转氨酶(AST)检测及肝组织病理学检测.结果 高脂饮食喂养6个月后成功建立小鼠脂肪肝模型;Western blot证实A组小鼠UCP-2无表达,C组表达明显高于B组;A组ALT、AST、ATP、ROS、LDH的定量值为:(55.33±5.51)、(128.33±7.02)U/L、(28.00±2.00)nmol/L、(165.33±7.09)、(1176.00±22.27)U/pmt;B组上述指标为(25.00±4.58)、(85.33±4.51)U/L、(24.33±4.16)nmol/L、(147.33±7.51)、(707.33±31.64)U/prot;C组为(142.67±13.01)、(220.67±7.02)U/L、(8.67±1.53)nmol/L、(65.00±5.00)、(1748.33±42.52)U/prot,A组和C组差异有统计学意义(P<0.05);病理检测表明A组损伤轻于C组.结论 抑制解耦联蛋白-2基因表达能在减轻小鼠脂肪肝急性损伤.
目的 觀察解耦聯蛋白-2(UCP-2)基因在脂肪肝缺血再灌註損傷中的作用,探討以UCP-2為靶點的脂肪供肝預處理新途徑.方法 實驗動物分為3組:實驗組(A組):UCP-2基因敲除小鼠,給予高脂飲食(n=20);空白對照組(B組):野生型同繫小鼠,給予正常飲食(n=20);陰性對照組(C組):野生型同繫小鼠,給予高脂飲食(n=20).餵養6箇月,建屯小鼠脂肪肝模型.各組小鼠阻斷門靜脈缺血15 min,再灌註24 h後處死,檢測肝組織中UCP-2基因錶達及三燐痠腺苷(ATP)、活性氧族(ROS)、乳痠脫氫酶(LDH)水平;併行血清丙氨痠轉氨酶(ALT)、天門鼕氨痠轉氨酶(AST)檢測及肝組織病理學檢測.結果 高脂飲食餵養6箇月後成功建立小鼠脂肪肝模型;Western blot證實A組小鼠UCP-2無錶達,C組錶達明顯高于B組;A組ALT、AST、ATP、ROS、LDH的定量值為:(55.33±5.51)、(128.33±7.02)U/L、(28.00±2.00)nmol/L、(165.33±7.09)、(1176.00±22.27)U/pmt;B組上述指標為(25.00±4.58)、(85.33±4.51)U/L、(24.33±4.16)nmol/L、(147.33±7.51)、(707.33±31.64)U/prot;C組為(142.67±13.01)、(220.67±7.02)U/L、(8.67±1.53)nmol/L、(65.00±5.00)、(1748.33±42.52)U/prot,A組和C組差異有統計學意義(P<0.05);病理檢測錶明A組損傷輕于C組.結論 抑製解耦聯蛋白-2基因錶達能在減輕小鼠脂肪肝急性損傷.
목적 관찰해우련단백-2(UCP-2)기인재지방간결혈재관주손상중적작용,탐토이UCP-2위파점적지방공간예처리신도경.방법 실험동물분위3조:실험조(A조):UCP-2기인고제소서,급여고지음식(n=20);공백대조조(B조):야생형동계소서,급여정상음식(n=20);음성대조조(C조):야생형동계소서,급여고지음식(n=20).위양6개월,건둔소서지방간모형.각조소서조단문정맥결혈15 min,재관주24 h후처사,검측간조직중UCP-2기인표체급삼린산선감(ATP)、활성양족(ROS)、유산탈경매(LDH)수평;병행혈청병안산전안매(ALT)、천문동안산전안매(AST)검측급간조직병이학검측.결과 고지음식위양6개월후성공건립소서지방간모형;Western blot증실A조소서UCP-2무표체,C조표체명현고우B조;A조ALT、AST、ATP、ROS、LDH적정량치위:(55.33±5.51)、(128.33±7.02)U/L、(28.00±2.00)nmol/L、(165.33±7.09)、(1176.00±22.27)U/pmt;B조상술지표위(25.00±4.58)、(85.33±4.51)U/L、(24.33±4.16)nmol/L、(147.33±7.51)、(707.33±31.64)U/prot;C조위(142.67±13.01)、(220.67±7.02)U/L、(8.67±1.53)nmol/L、(65.00±5.00)、(1748.33±42.52)U/prot,A조화C조차이유통계학의의(P<0.05);병리검측표명A조손상경우C조.결론 억제해우련단백-2기인표체능재감경소서지방간급성손상.
Objective To investigate the role of uncoupling protein-2 (UCP-2) in ischemia-reperfusion-(P<0.05) induced injury and explore a new target for fatty donor hver pretreatment. Methods The animals were divided into 3 groups: experimental group (group A) : UCP2 gene knock-down mice, feeding on high-fat diet; blank control group (group B) : homologous series wild type mice, feeding on normal diet; na-gative control group (group C) : homologous series wild type mice, feeding on high-fat diet. Six months later, the mice in every group were sacrificed. The levels of adenosine-triphosphate (ATP), reactive oxygen species (ROS), lactate dehydrogenase (LDH) in hver tissues, and alanine tronsaminase (ALT), and asparate amin-otransferase (AST) in serum were determed. The pathologic changes were also examined. Results After feed-ing on high fat diet for 6 mouths, the model of fatty liver in mice was established. Western blotting con-firmed that the expression of UCP-2 mRNA was inhibited completely, and the expression level in group C was higher than in group B. The ALT, AST, ATP, ROS and LDH levels in group A were (55.33± 5.51), (128.33±7.02) U/L, (28.00±2.00) nmol/L, (165.33±7.09), (1176.00±22.27) U/prot, those in group B were (25.00±4.58), (85.33±4.51) U/L, (24.33±4.16) nmol/L, (147.33± 7.51), and (707.33±31.64) U/prot, and those in group C were (142.67±13.01), (220.67±7.02) U/L, (8.67±1.53 ) nmol/L, (65.00±5.00), (1748.33±42.52) U/prot, respectively. There was significant difference between group A and group C. Pathologic examination revealed that in group A, the ischemia-reperfusion-induced injury was milder than in group C. Conclusion Inhibiting the expression of UCP-2 attenuates the I/R injury of mouse fatty liver.